Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes

Journal of Diabetes and its Complications

Volumn 29, Issue 2, 2015, Pages 270-274

  Rigalleau, V ^a,b,c   Cougnard Gregoire, A ^b,c   Nov, S ^b,c   Gonzalez, C ^a,b   Maury, E ^a,b,c   Lorrain, S ^b,c   Gin, H ^a,b   Barberger Gateau, P ^b,c  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

Author keywords

Advanced glycation end products; Chronic kidney disease; Glomerular filtration rate; Macroangiopathy; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; AUTOFLUORESCENCE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC MICROANGIOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKIN AUTOFLUORESCENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FLUORESCENCE; FRANCE; METABOLISM; PATHOPHYSIOLOGY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SKIN; UPREGULATION;

AGE FACTORS; AGED; BIOMARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FLUORESCENCE; FRANCE; GLOMERULAR FILTRATION RATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SKIN; UP-REGULATION;

EID: 84922985760     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.10.011     Document Type: Article

References (25)

1. M. Afkarian, M.C. Sachs, B. Kestenbaum, I.B. Hirsch, K.R. Tuttle, and J. Himmelfarb Kidney disease and increased mortality risk in type 2 diabetes Journal of the American Society of Nephrology 24 2013 302 308
2. V.R. Aroda, B.N. Conway, S.J. Fernandez, N.I. Matter, J.D. Maynard, and T.J. Orchard Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin A1C in type 1 diabetes Diabetes Technology & Therapeutics 15 2013 117 123
3. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
4. P. Barat, B. Cammas, A. Lacoste, J. Harambat, V. Vautier, and F. Nacka Advanced glycation end products in children with type 1 diabetes: Family matters? Diabetes Care 35 2012 e1 10.2337/dc11-1398
5. P.A. Cleary, B.H. Braffett, T. Orchard, T.J. Lyons, J. Maynard, and C. Cowie Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes control and complications Trial/Epidemiology of diabetes Interventions and Complications Study Diabetes Technology & Therapeutics 15 2013 117 123
6. Mda S. de Souza, P.H. Lima, Y.K. Sinzato, M.V. Rudge, O.C. Pereira, and D.C. Damasceno Effects of cigarette smoke exposure on pregnancy outcome and offsprings of diabetic rats Reproductive Biomedicine Online 18 2009 562 567
7. D.L. Felipe, J.M. Hempe, S. Liu, N. Matter, J. Maynard, and C. Linares Skin intrinsic fluorescence is associated with HbA1C and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes Diabetes Care 34 2011 1816 1820
8. J.M. Forbes, M.E. Cooper, M.D. Oldfield, and C.T. Merlin Role of advanced glycation end products in diabetic nephropathy Journal of the American Society of Nephrology 14 2003 5254 5258
9. P. Gaede, L. Tarnow, P. Vedel, H.H. Parving, and O. Pedersen Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 dabetes and microalbuminuria Nephrology, Dialysis, Transplantation 19 2004 2784 2788
10. M. Geneviève, A. Vivot, C. Gonzalez, C. Raffaitin, P. Barberger-Gateau, and H. Gin Skin autofluorescence is associated with past glycemic control and complications in type 1 diabetes mellitus Diabetes & Metabolism 39 2013 349 354
11. E.G. Gerrits, H.L. Lutgers, N. Kleepstra, R. Graaf, K.H. Groenier, and A.J. Smit Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications Diabetes Care 31 2008 517 521
12. N.M. Hanssen, M. Engelen, I. Ferreira, J.L. Scheijen, M.S. Huijberts, and M.M. van Grevenbroek Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with our without type 2 diabetes: The Hoorn and CODAM studies The Journal of Clinical Endocrinology and Metabolism 98 2013 E1369 E1373
13. M. Koetsier, H.L. Lutgers, C. De Jonge, T.P. Links, A.J. Smit, and R. Graff Reference values of skin autofluorescence Diabetes Technology & Therapeutics 12 2010 399 403
14. H.L. Lutgers, R. Graaf, T.P. Links, L.J. Ubink-veltmaat, H.J. Bilo, and R.O. Gans Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes Diabetes Care 29 2006 2654 2659
15. K. Matsushita, B.K. Mahmoodi, M. Woodward, J.R. Emberson, T.H. Jafar, and S.H. Jee Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate JAMA 307 2012 1941 1951
16. R. Meerwaldt, R. Graaff, P.H.N. Oomen, T.P. Links, J.J. Jager, and N.L. Alderson Simple non-invasive assessment of advanced glycation endproduct accumulation Diabetologia 47 2004 1324 1330
17. R. Meerwaldt, J.W. Hartog, R. Graaff, R.J. Huisman, T.P. Links, and N.C. den Hollander Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients Journal of the American Society of Nephrology 16 2005 3687 3693
18. M. Monami, C. Lamanna, F. Gori, F. Bartalucci, N. Marchionni, and E. Mannucci Skin autofluorescence in type 2 diabetes: Beyond blood glucose Diabetes Research and Clinical Practice 79 1 2008 56 60
19. M.J. Noordzij, D.J. Mulder, P.H. Oomen, T. Brouwer, J. Jager, and M. Castro Cabezas Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus - A multi-centre study Diabetic Medicine 29 2012 1556 1561
20. J. Park Cardiovascular risk in chronic kidney disease: Role of the sympathetic nervous system Cardiology Research and Practice 319432 2012
21. H.H. Parving, F.S. Nielsen, L.E. Bang, U.M. Smidt, T.L. Svendsen, and J.W. Chen Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy Diabetologia 39 1996 1590 1597
22. R.D. Semba, E.J. Nicklett, and L. Ferrucci Does accumulation of advanced glycation end products contribute to the aging phenotype? The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 65A 2010 963 975
23. E. Sugisawa, J. Miura, Y. Iwamoto, and Y. Uchigata Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes Diabetes Care 36 2013 2339 2345
24. K. Tanaka, Y. Tani, J. Asai, F. Nemoto, Y. Kusano, and H. Suzuki Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients Nephrology, Dialysis, Transplantation 26 2011 214 220
25. K. Tanaka, Y. Tani, J. Asai, F. Nemoto, Y. Kusano, and H. Suzuki Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes Diabetic Medicine 29 2012 492 500